Literature DB >> 32401364

Sclerodermiform basal cell carcinomas vs. other histotypes: analysis of specific demographic, clinical and dermatoscopic features.

C Conforti1, M A Pizzichetta1,2, S Vichi1, F Toffolutti3, D Serraino3, N Di Meo1, R Giuffrida4, T Deinlein5, J Giacomel6, C Rosendahl7, J Y Gourhant8, I Zalaudek1.   

Abstract

BACKGROUND: Among the various types of basal cell carcinoma, the sclerodermiform variant has a high risk of recurrence and local invasiveness. A systematic description of the dermatoscopic features associated with specific body localization is lacking.
OBJECTIVES: To describe the clinical and dermoscopic features of sclerodermiform basal cell carcinoma (BCC) according to localization in the body confronting with superficial and nodular types.
METHODS: Clinical and dermoscopic images of sclerodermiform, nodular and superficial BCCs were retrospectively evaluated to study the location in the various body districts, maximum diameter, clinical appearance of the lesion, features of edges and presence or absence of specific dermatoscopic criteria of BCCs.
RESULTS: We examined 291 histopathologically proven BCCs showing that in nodular BCCs, classical arborizing vessels were more frequently found in the body macro-area (trunk and limbs; n = 46, 97.9%) than in the head/neck area (n = 43, 82.7%); within sclerodermiform BCCs, short arborizing vessels were found more frequently in the head/neck district (n = 35, 49.3%) than in the body (n = 6, 23.1%; P-value 0.02); within nodular BCCs, multiple blue-grey dots and globules were more frequently found on the trunk (n = 23, 48.9%) than in the head/neck district (n = 12, 23.1%; P-value 0.01). In sclerodermiform BCCs, ulceration was found more frequently in the head/neck district (n = 38, 53.5%) than in the body (n = 4, 15.4%; P-value > 0.01), and in superficial BCCs, ulceration was found more frequently in the head/neck district (n = 5, 38.5%) than in the body (n = 8, 9.8%; P-value 0.02).
CONCLUSION: Our study shows that superficial BCC are found frequently in the head/neck district dermoscopically characterized by ulceration and arborizing vessels; nodular BCCs are more frequently found in the body than in the head/neck district, and the dermoscopic pattern is characterized by the combination of three features: (i) classical arborizing vessels, (ii) multiple blue-grey dots and (iii) globules. Instead, sclerodermiform BCC is preferentially located in areas at high-moderate risk of recurrence; if pink-white areas and/or fine arborizing vessels are seen, clinicians should consider this diagnosis. Furthermore, location-specific dermatoscopic criteria have been described.
© 2020 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2020        PMID: 32401364     DOI: 10.1111/jdv.16597

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  3 in total

1.  Clinical and Dermoscopic Factors for the Identification of Aggressive Histologic Subtypes of Basal Cell Carcinoma.

Authors:  Riccardo Pampena; Gabriele Parisi; Mattia Benati; Stefania Borsari; Michela Lai; Giovanni Paolino; Anna Maria Cesinaro; Silvana Ciardo; Francesca Farnetani; Sara Bassoli; Giuseppe Argenziano; Giovanni Pellacani; Caterina Longo
Journal:  Front Oncol       Date:  2021-02-19       Impact factor: 6.244

2.  Differentiation-related epigenomic changes define clinically distinct keratinocyte cancer subclasses.

Authors:  Manuel Rodríguez-Paredes; Frank Lyko; Llorenç Solé-Boldo; Günter Raddatz; Julian Gutekunst; Oliver Gilliam; Felix Bormann; Michelle S Liberio; Daniel Hasche; Wiebke Antonopoulos; Jan-Philipp Mallm; Anke S Lonsdorf
Journal:  Mol Syst Biol       Date:  2022-09       Impact factor: 13.068

3.  Novel Insights for Patients with Multiple Basal Cell Carcinomas and Tumors at High-Risk for Recurrence: Risk Factors, Clinical Morphology, and Dermatoscopy.

Authors:  Dimitrios Sgouros; Dimitrios Rigopoulos; Ioannis Panayiotides; Zoe Apalla; Dimitrios K Arvanitis; Melpomeni Theofili; Sofia Theotokoglou; Anna Syrmali; Konstantinos Theodoropoulos; Georgia Pappa; Vasileia Damaskou; Alexander Stratigos; Alexander Katoulis
Journal:  Cancers (Basel)       Date:  2021-06-27       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.